Literature DB >> 14992369

Evaluation of hepatic focal nodular hyperplasia with contrast-enhanced gray scale harmonic sonography: initial experience.

Min Ju Kim1, Hyo K Lim, Seong Hyun Kim, Dongil Choi, Won Jae Lee, Soon Jin Lee, Jae Hoon Lim.   

Abstract

OBJECTIVE: To assess the potential of contrast-enhanced gray scale harmonic sonography in the evaluation of the typical vascular and enhancement patterns of hepatic focal nodular hyperplasia.
METHODS: Thirteen patients with 13 lesions of hepatic focal nodular hyperplasia underwent contrast-enhanced gray scale harmonic sonography. After the injection of a microbubble contrast agent (SH U 508A), gray scale harmonic sonographic studies using a Coded Harmonic Angio technique were performed with a combination of a period of continuous scanning to assess the vascular pattern (vascular imaging) and interval delay scanning to determine the sequential enhancement pattern (acoustic emission imaging). Each imaging pattern was categorized and analyzed by consensus of 2 experienced radiologists.
RESULTS: In 12 (92%) of 13 lesions, vascular imaging during the arterial phase showed central arteries of a spoked wheel pattern, whereas the remaining lesion had stippled vascularity. On acoustic emission imaging, 11 (85%) of 13 lesions were hyperechoic during the early phase, and the remaining 2 (15%) were isoechoic compared with surrounding parenchyma. Ten (77%) of 13 lesions remained either hyperechoic (5 of 13) or isoechoic (5 of 13) during the delay phase, whereas the remaining 3 lesions (23%) were hypoechoic.
CONCLUSIONS: Contrast-enhanced gray scale harmonic sonography showed the typical vascularity of a spoked wheel pattern during the vascular phase and persistent enhancement on serial acoustic emission imaging in most cases of hepatic focal nodular hyperplasia, and thereby it can be a promising technique in noninvasive diagnosis of this entity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14992369     DOI: 10.7863/jum.2004.23.2.297

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  7 in total

Review 1.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

2.  Use of accumulation images obtained by arterial-phase contrast-enhanced harmonic grayscale ultrasonography to evaluate tumor vessels in focal nodular hyperplasia and other hepatic tumors.

Authors:  Kazushi Numata; Manabu Morimoto; Tetsuo Isozaki; Kazuya Sugimori; Hiroyuki Oka; Kenichi Matsuo; Hiroshi Shimada; Toshio Imada; Katsuaki Tanaka
Journal:  J Med Ultrason (2001)       Date:  2007-03-15       Impact factor: 1.314

3.  Contrast-enhanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-enhanced CT.

Authors:  Wei Wang; Li-Da Chen; Ming-De Lu; Guang-Jian Liu; Shun-Li Shen; Zuo-Feng Xu; Xiao-Yan Xie; Yan Wang; Lu-Yao Zhou
Journal:  Eur Radiol       Date:  2013-04-27       Impact factor: 5.315

4.  Focal nodular hyperplasia of the liver: a sequela of tumor therapy.

Authors:  Benny L Joyner; Terry L Levin; Rakesh K Goyal; Beverley Newman
Journal:  Pediatr Radiol       Date:  2005-07-29

5.  Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound.

Authors:  Riccardo Lencioni
Journal:  Eur Radiol       Date:  2006-02-21       Impact factor: 5.315

6.  Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma.

Authors:  X-Q Pei; L-Z Liu; Y-H Xiong; R-H Zou; M-S Chen; A-H Li; M-Y Cai
Journal:  Br J Radiol       Date:  2013-02-07       Impact factor: 3.039

Review 7.  Benign Liver Tumors.

Authors:  Karl J Oldhafer; Victoria Habbel; Katja Horling; Georgios Makridis; Kim Caroline Wagner
Journal:  Visc Med       Date:  2020-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.